High-stakes heterogeneity in COVID-19
- PMID: 32989434
- PMCID: PMC7511174
- DOI: 10.1016/S2665-9913(20)30310-6
High-stakes heterogeneity in COVID-19
Comment on
-
COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study.Lancet Rheumatol. 2020 Oct;2(10):e594-e602. doi: 10.1016/S2665-9913(20)30275-7. Epub 2020 Aug 21. Lancet Rheumatol. 2020. PMID: 32864628 Free PMC article.
-
COVACTA trial raises questions about tocilizumab's benefit in COVID-19.Lancet Rheumatol. 2020 Oct;2(10):e592. doi: 10.1016/S2665-9913(20)30313-1. Epub 2020 Sep 9. Lancet Rheumatol. 2020. PMID: 32929415 Free PMC article. No abstract available.
Similar articles
-
Effort in Low-Stakes Assessments: What Does It Take to Perform as Well as in a High-Stakes Setting?Educ Psychol Meas. 2016 Dec;76(6):1045-1058. doi: 10.1177/0013164416634789. Epub 2016 Mar 4. Educ Psychol Meas. 2016. PMID: 29795900 Free PMC article.
-
Student Experiences of High-stakes Testing for Progression in One Undergraduate Nursing Program.Int J Nurs Educ Scholarsh. 2018 Feb 8;15(1):/j/ijnes.2018.15.issue-1/ijnes-2017-0001/ijnes-2017-0001.xml. doi: 10.1515/ijnes-2017-0001. Int J Nurs Educ Scholarsh. 2018. PMID: 29425109
-
Ethical Acceptability of Postrandomization Consent in Pragmatic Clinical Trials.JAMA Netw Open. 2018 Dec 7;1(8):e186149. doi: 10.1001/jamanetworkopen.2018.6149. JAMA Netw Open. 2018. PMID: 30646316 Free PMC article.
-
High-Stakes Testing in Nursing Education: A Review of the Literature.Nurse Educ. 2018 Jul/Aug;43(4):183-186. doi: 10.1097/NNE.0000000000000475. Nurse Educ. 2018. PMID: 29135716 Review.
-
[Stakes, aims and specificities of the physician-patient communication in cancer care: state of the art and perspectives].Bull Cancer. 2006 Apr;93(4):357-62. Bull Cancer. 2006. PMID: 16627240 Review. French.
Cited by
-
Severe COVID-19 in the intensive care unit: a case series.J Med Case Rep. 2021 May 3;15(1):259. doi: 10.1186/s13256-021-02799-1. J Med Case Rep. 2021. PMID: 33941249 Free PMC article.
-
Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies.Front Immunol. 2022 Jul 26;13:893943. doi: 10.3389/fimmu.2022.893943. eCollection 2022. Front Immunol. 2022. PMID: 35958562 Free PMC article.
-
Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure.Sci Rep. 2021 Oct 4;11(1):19675. doi: 10.1038/s41598-021-99102-5. Sci Rep. 2021. PMID: 34608231 Free PMC article.
-
COVID-19: immunopathology, pathophysiological mechanisms, and treatment options.J Pathol. 2021 Jul;254(4):307-331. doi: 10.1002/path.5642. Epub 2021 Mar 25. J Pathol. 2021. PMID: 33586189 Free PMC article. Review.
-
Interpretable clinical phenotypes among patients hospitalized with COVID-19 using cluster analysis.Front Digit Health. 2023 Apr 11;5:1142822. doi: 10.3389/fdgth.2023.1142822. eCollection 2023. Front Digit Health. 2023. PMID: 37114183 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources